A Study to Evaluate Safety and Tolerability of Subcutaneous Doses of MEDI-545 in Subjects With Lupus
Public ClinicalTrials.gov record NCT00657189. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2A , Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Dose Study to Evaluate the Safety and Tolerability of Multiple Subcutaneous Doses of MEDI-545, A Fully Human Anti-Interferon-Alpha Monoclonal Antibody, In Subjects With Systemic Lupus Erythematosus
Study identification
- NCT ID
- NCT00657189
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- MedImmune LLC
- Industry
- Enrollment
- 87 participants
Conditions and interventions
Conditions
Interventions
- MEDI-545 Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2008
- Primary completion
- Apr 30, 2010
- Completion
- Apr 30, 2010
- Last update posted
- Aug 8, 2016
2008 – 2010
United States locations
- U.S. sites
- 22
- U.S. states
- 15
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Anniston | Alabama | 36207 | — |
| Research Site | Huntington Beach | California | 92646 | — |
| Research Site | Upland | California | 91786 | — |
| Research Site | Colorado Springs | Colorado | 80910 | — |
| Research Site | Farmington | Connecticut | 06030-5353 | — |
| Research Site | Clearwater | Florida | 33765-2616 | — |
| Research Site | Ocala | Florida | 34474 | — |
| Research Site | Atlanta | Georgia | 30303 | — |
| Research Site | Decatur | Georgia | 30033 | — |
| Research Site | Marrietta | Georgia | 30060 | — |
| Research Site | West Fayetteville | Georgia | 30269 | — |
| Research Site | Baltimore | Maryland | 21205 | — |
| Research Site | Lansing | Michigan | 48910 | — |
| Research Site | Brooklyn | New York | 10003 | — |
| Research Site | Charlotte | North Carolina | 28210 | — |
| Research Site | Cincinnati | Ohio | 45219 | — |
| Research Site | Oklahoma City | Oklahoma | 73104 | — |
| Research Site | Charleston | South Carolina | 29406 | — |
| Research Site | Columbia | South Carolina | 29204 | — |
| Research Site | Houston | Texas | 77004 | — |
| Research Site | Sugarland | Texas | 77479 | — |
| Research Site | Seattle | Washington | 98111 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00657189, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 8, 2016 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00657189 live on ClinicalTrials.gov.